Elevance Health Inc.

(New York Stock Exchange)
Back to all articles
Bullish +55

Elevance Health stock costs EUR 371.95 with P/ E 18.5

Analyst upgrade AI-generated analysis

πŸ“ˆ Elevance Health stock gained 2.79 percent to EUR 371.95 on October 9, 2026.

πŸ’° The company trades at a P/E ratio of 18.5 with a market capitalization of USD 90.3 billion.

🎯 Analysts maintain an average 12-month target price of USD 440.90, suggesting upside potential.

πŸ“Š Barclays raised its price target to USD 469.00 while keeping an Overweight rating on the stock.

πŸ—“οΈ Third-quarter 2026 financial results are scheduled for release on October 21, 2026.

πŸ“‰ The NYSE quote is currently 4.59 percent below its 52-week high of USD 436.24.

Bullish Signals
  • Elevance Health stock rose 2.79 percent to EUR 371.95, indicating positive market sentiment.
  • Barclays raised its price target from USD 457.00 to USD 469.00 while maintaining an Overweight rating.
  • MarketBeat data shows that 15 out of 23 analysts recommend buying the stock, reflecting strong buy-side interest.
Risk Factors
  • The stock is trading 4.59 percent below its 52-week high of USD 436.24, indicating some near-term consolidation.
  • Trading volume increased to 1,248,089 shares, which is above the average but does not confirm a breakout.
Full Analysis
Elevance Health stock rose 2.79 percent to EUR 371.95 on October 9, 2026, trading at a P/E ratio of 18.5 and a market capitalization of USD 90.3 billion. The NYSE quote stood at USD 416.21, positioning the stock 4.59 percent below its 52-week high of USD 436.24 while remaining significantly above its low. Analyst sentiment remains positive with an average 12-month target price of USD 440.90 from 23 analysts. Barclays recently raised its target to USD 469.00, maintaining an Overweight rating, while MarketBeat data indicates that 15 of the 23 analysts recommend buying the stock. The company is preparing to release its third-quarter 2026 financial results on October 21, 2026, ahead of a conference call scheduled for 8:30 a.m. EDT. Trading volume increased by 5.24 percent compared to the average, reflecting active investor interest in the healthcare insurer's performance.